What is UroGen Pharma's debt-to-equity?

UroGen Pharma (URGN) reported debt-to-equity of 4.8× in Q3 2024.

What does debt-to-equity mean?

Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.

UroGen Pharma URGN Debt-to-equity

Debt-to-equity at other companies

Bristol-Myers SquibbBMY

2.2×-0.6×

PfizerPFE

0.7×0.0×

Johnson & JohnsonJNJ

0.7×0.0×

Merck & Co.MRK

1.1×+0.3×

Tyra Biosciences, Inc.TYRA

0×0.0×

CG OncologyCGON

0×0.0×

Other financials

Income statement

See full

Revenue$51.0M+152%

Gross profit$11.6M—

Operating income-$22.8M—

Net income-$23.6M+46.2%

EPS (diluted)-$1.17—

Balance sheet

See full

Cash & equivalents$110.0M+5.7%

Total debt$197.1M+56.0%

Total equity-$124.3M-167%

Total assets$253.7M+2.5%

Cash flow

See full

Operating cash flow-$45.3M-7.8%

CapEx$54.0K+22.7%

Free cash flow-$45.4M-7.8%

Valuation

See full

Market cap$1.71B+71.7%

Enterprise value$1.8B+80.9%

P/S12.2×+1.3×

Profitability

See full

Gross margin89.7%—

Operating margin-329.7%—

Net margin-94.8%-25.6pp

FCF margin-118.2%+1.3pp

Returns & leverage

See full

Return on equity-211.6%—

Current ratio4.7×-1.0×

Where this comes from

Calculated from UroGen Pharma’s reported figures.

total debt/total stockholders equity=4.8×

Based on the most recent quarter.

The official record: UroGen Pharma’s 10-Q, filed November 6, 2024, on SEC EDGAR. View the filing →

Ask your AI about UroGen Pharma's debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is UroGen Pharma's debt-to-equity?: UroGen Pharma (URGN) reported debt-to-equity of 4.8× in Q3 2024.
What does debt-to-equity mean?: Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.